Short Interest in Enzolytics, Inc. (OTCMKTS:ENZC) Increases By 7.9%

Enzolytics, Inc. (OTCMKTS:ENZC) was the target of a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 314,000 shares, an increase of 7.9% from the June 15th total of 291,000 shares. Based on an average daily volume of 33,798,400 shares, the days-to-cover ratio is presently 0.0 days.

Enzolytics Stock Up 5.9 %

Enzolytics stock opened at $0.00 on Wednesday. Enzolytics has a 52-week low of $0.00 and a 52-week high of $0.06.

Enzolytics Company Profile

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.